This curriculum is intended to build confidence in applying strategies for the prevention and management of thromboembolic disease and to ensure best practices across all clinical indications and care settings. Adherence concerns and patient uncertainty can be alleviated by ensuring that patients are educated by their provider on the differences between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin, why monitoring is not required for NOACs, and the importance of adherence to prescribed therapy.
Participation by Dr Streiff as an advisor does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.
Michael B. Streiff, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Janssen Pharmaceuticals; Portola Pharmaceuticals, Inc.
Served as a paid member of committee, panel, or board for BiO2 Medical Inc.
Jack E. Ansell, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alere; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Janssen Pharmaceuticals; Instrumentation Laboratory; Perosphere; Pfizer Inc; Roche
Owns equity in: Perosphere
Elaine M. Hylek, MD, MPH, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Janssen Pharmaceuticals; Medtronic, Inc.; Pfizer Inc
Received honoraria from: Bayer HealthCare Pharmceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company
Alok A. Khorana, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AngioDynamics, Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Halozyme Therapeutics; Janssen Pharmaceuticals; Leo Pharma Inc.; Pfizer Inc; Roche
Served as a paid member of committee, panel, or board for Janssen Pharmaceuticals; Leo Pharma Inc.
Manesh R. Patel, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bayer HealthCare Pharmaceuticals; Genzyme Corporation; Merck & Co., Inc.
Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Bayer HealthCare Pharmaceuticals; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; MAQUET, Inc.
Alex C. Spyropoulos, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bayer Healthcare, Bristol-Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Janssen Pharmaceuticals; Pfizer Inc
Received grants for clinical research from Boehringer Ingelheim Pharmaceuticals, Inc.; Janssen Pharmaceuticals